Author Question: Remains found in __________ and __________ provide the best evidence for the Multiregional Model. ... (Read 56 times)

joesmith1212

  • Hero Member
  • *****
  • Posts: 549
Remains found in __________ and __________ provide the best evidence for the Multiregional Model.
 
  a. Africa; Greece
  b. Europe; North America
  c. Asia; Australia
  d. Africa; North America

Question 2

Which of the following is a way that Upper Paleolithic burials differed from Mousterian burials?
 
  a. Upper Paleolithic burials were in pits.
  b. Upper Paleolithic remains were intentionally commingled.
  c. Upper Paleolithic burials did not have burial goods.
  d. Upper Paleolithic burials are more difficult to study due to the type of geological stratum in which they are buried.



Heffejeff

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

Correct Answer: c

Answer to Question 2

Correct Answer: a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Though the United States has largely rejected the metric system, it is used for currency, as in 100 pennies = 1 dollar. Previously, the British currency system was used, with measurements such as 12 pence to the shilling, and 20 shillings to the pound.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library